Investors, Don’t Forget There’s Life After 60

The aging of the global population is having a profound impact on consumers, companies and investors.

There is a massive, irreversible transformation under way in the U.S. and across the globe. It is poorly understood and often overlooked. Halfway through the second decade of our 21st century, we are failing to grasp the implications of population aging.

Life spans that have for the history of humankind been unimaginable are today the norm. Low birth rates that for centuries would have spelled the end of a civilization are now common. By midcentury, there will be more of us over 60 than under 14. A half century ago this demographic state of affairs would have been inconceivable.

The implications are profound. At personal and familial levels, each of us must ask a new set of questions about how to achieve financial security when we may live to celebrate our 100th birthday. At the societal level we confront a retirement crisis prompted by our stubborn refusal to recognize that 20th-century schemes don’t fit 21st-century lives. Retirement at 60 or 65 will make sense for very few among us when we must plan to live past 90.

The questions are equally complex for investors. First, there is the business opportunity. There will soon be 1 billion of us over 60, and we hold the lion’s share of the world’s disposable income. With longer lives – and better health in older age – a new consumer base emerges. These consumers want and need products and services that are different from when they were younger – and different, too, from what their parents wanted at their age.

As hundreds of millions of us live into our 80s and beyond, our tastes literally are changing, along with our body shapes, living conditions and leisure preferences. Which businesses are preparing to capitalize on this seismic opportunity?

Sure, health companies understand the diseases of aging; financial institutions are starting to get it too. But are there food companies creating products specifically for 75-year-old taste buds? Which travel company is accommodating the interests of and marketing to older travelers? Who is creating houses, appliances, furniture and other home goods for octogenarians? Which film companies are making movies that appeal to older viewers? Is there a technology company building the wearables market to assist the deteriorating hearing, vision and skin? What innovator is out there marrying fashion and need – dresses, shoes or bathing suits for the over-70 crowd?

The smart investor will look beyond the “baby boomer bulge” headlines and recognize that aging is not a trend but a revolutionary transformation. All over the world socioeconomic forces – urbanization, education, women’s rights, health care innovation and more – are intersecting to create real, enduring change. The smart investor will understand this is now a part of consumer demand writ large.

For investors the aging megatrend introduces a new set of metrics by which to measure the potential success of a company.

  • Is a culture of “age-friendliness” being cultivated within the organization? Will research, business development, strategy and marketing teams be recognized and rewarded for creative approaches to products and services that will sell to over-60 consumers?
  • Has population aging also shaped hiring and retention strategies? Paying retirement at 65 worked 50 years ago because there were so few who lived much past that age and most people could not or did not want to work as they got older. Now, it is a recipe for failure.
  • Is the company investing in research or marketing that will attend to an older demographic? Does it have a growth strategy based on aging?
  • Which companies are reshaping their benefits packages to attract and retain talent? And does this include benefits a 55-year-old might want as well as those for the 32-year-old who will be around for 60 or more years?
  • Does the organization have a strategic approach to align its future with the social, political and institutional changes that will occur externally as a result of the phenomenon?

In 2010, S&P, now a division of McGraw Hill Financial, broke important ground in its Global Aging report, asserting that “no other force is likely to shape the future of national economic health, public finances and policymaking as the irreversible rate at which the world’s population is aging.” Six years later we now understand that aging is equally a market force.

If a business wishes to be competitive and win in the 21st century, it will build a strategy to capture the opportunities brought by population aging. If an investor wants to succeed, he or she will look to these leaders as among the most prescient and worthy of investment.

Source: Institutional Investor

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

Joe Biden’s ‘Cancer Moonshot’ May be Derailed by New Policies, Including His Own

For almost a decade, President Biden has championed a bold “cancer moonshot” — an initiative he first launched in 2016, revived early in his administration, and reiterated during this year’s State of the Union. It is a laudable goal, especially for an aging nation where cancer and chronic disease are on the rise. There’s just one problem: Recent federal and state policies are poised to derail the incredible progress made in oncology since 2016. A rash of policies now threatens to limit access and slow progress towards new breakthroughs.

Global Coalition on Aging, Leading G7 Government Officials, Call for Incentivized Antibiotic Innovation

The Global Coalition on Aging (GCOA), in partnership with the Japanese Pharmaceutical Manufacturer’s Association (JPMA), and public health leaders call on G7 governments to fund pull incentives and make “fair share” investments in antibiotic innovation to fight the global antimicrobial resistance (AMR) crisis. GCOA, JPMA, and health and government officials from the European Union, Italy, Japan, and United Kingdom recently convened to discuss how G7 countries must respond. GCOA today published a report detailing takeaways from the closed-door meeting, “The Role of G7 Governments in Global Efforts to Encourage Antimicrobial Development Through a Pull Incentive: Challenges and Collaboration.”

Kishida and Biden Face a Similar Demographic Crisis

Your front page story “Japan wrestles with age-old problem as population declines at record rate” (Report, April 13) and the letter in the same edition from Tim Hill, “A gently declining population is no reason to panic”, both describe what all societies face as they modernise in the 21st century.

2024 AMR Preparedness Index Progress Report Highlights Urgent Need For Global Action Against Antimicrobial Resistance

Today, the Global Coalition on Aging (GCOA) and the Infectious Diseases Society of America (IDSA) launched the 2024 AMR Preparedness Index Progress Report. Released in the lead up to the United Nations General Assembly 2024 High-level Meeting on Antimicrobial Resistance (AMR) this September, the 2024 Progress Report assesses how the eleven largest global economies have advanced on calls to action laid out in the 2021 AMR Preparedness Index.

New Global Analysis Across Five Cities Shows Inequities in Adult Immunization Uptake, Signaling Need to Redesign Local and National Policy Interventions

GSK, in collaboration with the Global Coalition on Aging (GCOA), announced a new report from the IQVIA Institute for Human Data Science (IQVIA Institute). The report, funded by GSK, explores the role of social and structural determinants of health in adult vaccine access and uptake across five global cities with strong data about their aging populations: Bangkok, Thailand; Brussels, Belgium; Chicago, US; Manchester, United Kingdom; and New York City, US.

New Report From the Global Coalition on Aging Highlights the Connection Between Adult Immunization and Economic Health in Aging APEC Region

As leaders from across the Asia-Pacific Economic Cooperation (APEC) region convene in San Francisco over the next week, a new report from the Global Coalition on Aging (GCOA) points to investments in healthy aging as a growing economic imperative amid the region’s changing demographics. According to the new report, programs that keep populations healthy, active, and productive – like adult immunization – are increasingly becoming a prerequisite for economic stability and growth.